Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
The Journal of Urology
|
November 9, 2019
Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
The Journal of Urology
|
January 23, 2020
Reply by Authors
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2019
Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma
Wenxin Xu, Maneka Puligandla, Judith Manola, et al.
Blood Advances
|
January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease
Joshua J Field, Elaine Majerus, Victor R Gordeuk, et al.
American Journal of Hematology
|
October 9, 2018
Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident
Larysa Poluben, Maneka Puligandla, Donna Neuberg, et al.
JCI Insight
|
January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
Jeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
BJU International
|
September 4, 2021
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805
Jose A Karam, Maneka Puligandla, Keith T Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805
Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, et al.
Blood Advances
|
May 14, 2021
Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries
Fabiola Valvert, Oscar Silva, Elizabeth Solórzano-Ortiz, et al.
Clinical Genitourinary Cancer
|
July 16, 2023
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808
Bradley C Carthon, Se Eun Kim, David F McDermott, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
The Journal of Urology
|
November 9, 2019
Phase II Trial of Neoadjuvant Systemic Chemotherapy Followed by Extirpative Surgery in Patients with High Grade Upper Tract Urothelial Carcinoma
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
The Journal of Urology
|
January 23, 2020
Reply by Authors
Vitaly Margulis, Maneka Puligandla, Edouard J Trabulsi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 1, 2019
Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma
Wenxin Xu, Maneka Puligandla, Judith Manola, et al.
Blood Advances
|
January 4, 2018
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease
Joshua J Field, Elaine Majerus, Victor R Gordeuk, et al.
American Journal of Hematology
|
October 9, 2018
Characteristics of myeloproliferative neoplasms in patients exposed to ionizing radiation following the Chernobyl nuclear accident
Larysa Poluben, Maneka Puligandla, Donna Neuberg, et al.
JCI Insight
|
January 18, 2019
Targeting protein disulfide isomerase with the flavonoid isoquercetin to improve hypercoagulability in advanced cancer
Jeffrey I Zwicker, Benjamin L Schlechter, Jack D Stopa, et al.
BJU International
|
September 4, 2021
Adjuvant therapy in patients with sarcomatoid renal cell carcinoma: post hoc analysis from Eastern Cooperative Oncology Group-American College of Radiology Imaging Network (ECOG-ACRIN) E2805
Jose A Karam, Maneka Puligandla, Keith T Flaherty, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 26, 2017
Tumor Microvessel Density as a Prognostic Marker in High-Risk Renal Cell Carcinoma Patients Treated on ECOG-ACRIN E2805
Lucia B Jilaveanu, Maneka Puligandla, Sarah A Weiss, et al.
Blood Advances
|
May 14, 2021
Low-cost transcriptional diagnostic to accurately categorize lymphomas in low- and middle-income countries
Fabiola Valvert, Oscar Silva, Elizabeth Solórzano-Ortiz, et al.
Clinical Genitourinary Cancer
|
July 16, 2023
Results From a Randomized Phase II Trial of Sunitinib and Gemcitabine or Sunitinib in Advanced Renal Cell Carcinoma with Sarcomatoid Features: ECOG-ACRIN E1808
Bradley C Carthon, Se Eun Kim, David F McDermott, et al.
Page
of 3